Agreed, though without DD skills, he has better changes on big board stock picks or just spy, or cds, mutual funds. The advantage is big board has a higher return on average compared to otc, which is highly negative. So, if your DD is just picking random stocks and hoping for luck, stick to big board. OTC can give amazing returns though, which draws people in, mostly on very little company potential. Having something like leronlimab on otc is incredible rare. Having researching sometimes 5-10 otc stocks per day for trading, so hundreds per year, I haven’t came across anything with this potential. Many otc are excited with $1M in potential revs, here it could reach billions. They probably should have gotten off otc years ago, maybe with the excitement when Charlie came.
https://www.sec.gov/files/White_OutcomesOTCinvesting.pdf
For example, Brüggemann et al. (2016) study a sample of over 10,000 OTC stocks from 2001 to 2010 and find average and median annual returns of –27% and –37%, respectively. Similarly, Eraker and Ready (2015) study a sample of approximately 6,800 OTC stocks between 2000 and 2008. The investors in their sample average a –24% annual return after accounting for transaction costs.